The negative expression of CD103 is associated with splenic marginal zone lymphoma and mantle cell lymphoma, and the pathogenic mechanism may be related to the change in interaction between CD103 and E-cadherin (Santos et al., 2017). The gene discussed is CDH1; the disease is mantle cell lymphoma.